日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1

突变型 NPM1 的存在与新型治疗药物对具有突变型 NPM1 的 AML 细胞的疗效存在因果关系

Christopher P Mill #, Warren Fiskus #, Kaberi Das, John A Davis, Christine E Birdwell, Tapan M Kadia, Courtney D DiNardo, Naval Daver, Koichi Takahashi, Koji Sasaki, Gerard M McGeehan, Xinjia Ruan, Xiaoping Su, Sanam Loghavi, Hagop Kantarjian, Kapil N Bhalla

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)

针对 MLL 重排或 NPM1 突变 (NPM1c) 的 AML 的有效 Menin 抑制剂组合

Warren Fiskus, Steffen Boettcher, Naval Daver, Christopher P Mill, Koji Sasaki, Christine E Birdwell, John A Davis, Koichi Takahashi, Tapan M Kadia, Courtney D DiNardo, Qi Jin, Yuan Qi, Xiaoping Su, Gerard M McGeehan, Joseph D Khoury, Benjamin L Ebert, Kapil N Bhalla

BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma

针对 Richter 转化型弥漫大 B 细胞淋巴瘤新型模型的 BET 蛋白水解靶向嵌合体治疗

Warren Fiskus #, Christopher P Mill #, Dimuthu Perera, Christine Birdwell, Qing Deng, Haopeng Yang, Bernardo H Lara, Nitin Jain, Jan Burger, Alessandra Ferrajoli, John A Davis, Dyana T Saenz, Wendy Jin, Cristian Coarfa, Craig M Crews, Michael R Green, Joseph D Khoury, Kapil N Bhalla

Inhibition of GATA2 in prostate cancer by a clinically available small molecule

临床上可用的小分子抑制前列腺癌中的 GATA2

Salma Kaochar, Aleksandra Rusin, Christopher Foley, Kimal Rajapakshe, Matthew Robertson, Darlene Skapura, Cammy Mason, Karen Berman De Ruiz, Alexey Mikhailovich Tyryshkin, Jenny Deng, Jin Na Shin, Warren Fiskus, Jianrong Dong, Shixia Huang, Nora M Navone, Christel M Davis, Erik A Ehli, Cristian Coar

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma

TCF4(E2-2)的靶向基因改变可驱动弥漫大 B 细胞淋巴瘤中的免疫球蛋白表达

Neeraj Jain, Keenan Hartert, Saber Tadros, Warren Fiskus, Ondrej Havranek, Man Chun John Ma, Alyssa Bouska, Tayla Heavican, Dhiraj Kumar, Qing Deng, Dalia Moore, Christine Pak, Chih Long Liu, Andrew J Gentles, Elena Hartmann, Robert Kridel, Karin Ekstrom Smedby, Gunnar Juliusson, Richard Rosenquist,

Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells

BET 蛋白抑制剂与 BCL2 或 MCL1 抑制剂联合治疗对 AML 原始细胞祖细胞具有更优疗效

Warren Fiskus, Tianyu Cai, Courtney D DiNardo, Steven M Kornblau, Gautam Borthakur, Tapan M Kadia, Naveen Pemmaraju, Prithviraj Bose, Lucia Masarova, Kimal Rajapakshe, Dimuthu Perera, Cristian Coarfa, Christopher P Mill, Dyana T Saenz, David N Saenz, Baohua Sun, Joseph D Khoury, Yu Shen, Marina Kono

SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents

SIRT2 脱乙酰化并抑制过氧化物酶-1 的过氧化物酶活性,使乳腺癌细胞对氧化应激诱导剂敏感

Warren Fiskus, Veena Coothankandaswamy, Jianguang Chen, Hongwei Ma, Kyungsoo Ha, Dyana T Saenz, Stephanie S Krieger, Christopher P Mill, Baohua Sun, Peng Huang, Jeffrey S Mumm, Ari M Melnick, Kapil N Bhalla

Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib

BET 蛋白拮抗剂组合对对伊布替尼敏感或耐药的套细胞淋巴瘤细胞的协同作用

Baohua Sun, Bhavin Shah, Warren Fiskus, Jun Qi, Kimal Rajapakshe, Cristian Coarfa, Li Li, Santhana G T Devaraj, Sunil Sharma, Liang Zhang, Michael L Wang, Dyana T Saenz, Stephanie Krieger, James E Bradner, Kapil N Bhalla

BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD

BET 蛋白拮抗剂 JQ1 与 FLT3 酪氨酸激酶抑制剂 (TKI) 具有协同杀伤作用,并克服了表达 FLT-ITD 的 AML 细胞对 FLT3-TKI 的耐药性

Warren Fiskus, Sunil Sharma, Jun Qi, Bhavin Shah, Santhana G T Devaraj, Christopher Leveque, Bryce P Portier, Swaminathan Iyer, James E Bradner, Kapil N Bhalla

Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells

组蛋白去乙酰化酶抑制剂治疗可诱导“BRCAness”并与 PARP 抑制剂和顺铂一起对人类三阴性乳腺癌细胞产生协同杀伤力

Kyungsoo Ha, Warren Fiskus, Dong Soon Choi, Srividya Bhaskara, Leandro Cerchietti, Santhana G T Devaraj, Bhavin Shah, Sunil Sharma, Jenny C Chang, Ari M Melnick, Scott Hiebert, Kapil N Bhalla